Cargando…
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study
Breakthrough invasive fungal diseases (bIFDs) during voriconazole treatment are concerning, as they are associated with high rates of mortality and pathogen distribution. To evaluate the prevalence, incidence, patient characteristics, including IFD events, and overall mortality of bIFDs during voric...
Autores principales: | Kim, Sun Bean, Cho, Sung-Yeon, Lee, Dong-Gun, Choi, Jae-Ki, Lee, Hyo-Jin, Kim, Si-Hyun, Park, Sun Hee, Choi, Su-Mi, Choi, Jung-Hyun, Yoo, Jin-Hong, Lee, Jong-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654366/ https://www.ncbi.nlm.nih.gov/pubmed/27562861 http://dx.doi.org/10.1093/mmy/myw067 |
Ejemplares similares
-
Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population
por: Kim, Si-Hyun, et al.
Publicado: (2013) -
Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents
por: Kim, Si-Hyun, et al.
Publicado: (2018) -
Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species
por: Cho, Sung-Yeon, et al.
Publicado: (2017) -
Prognosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases in Korea
por: Kwon, Jae-Cheol, et al.
Publicado: (2012) -
Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study
por: Lee, Raeseok, et al.
Publicado: (2022)